Medicare Enrolled
Dr. Hafeez Chatoor, M.D.
Hematology · Tampa, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chatoor from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chatoor? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chatoor
Dr. Hafeez Chatoor is a hematology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Chatoor performed 103,326 Medicare services across 2,864 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chatoor received a total of $24,279 from 98 pharmaceutical and/or device companies across 1237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chatoor is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 44% volume in FL$ $24,279 industry payments
Medicare Practice Summary
Medicare Utilization ↗103,326
Medicare services
Top 44% in FL for hematology
2,864
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,438 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 33,660 | $0 | $4 |
| Iron sucrose injection (Venofer) | 25,600 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 12,480 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 10,187 | $6 | $23 |
| Immune globulin infusion (Gammagard) | 7,798 | $36 | $108 |
| Complete blood count (CBC) with differential | 1,961 | $8 | $29 |
| Contrast dye for imaging (iodine-based) | 1,875 | $0 | $1 |
| Blood draw (venipuncture) | 1,841 | $8 | $9 |
| Iron infusion (Monoferric) | 1,800 | $17 | $57 |
| Office visit, established patient (30-39 min) | 1,133 | $94 | $339 |
| Drug injection, under skin or into muscle | 1,050 | $10 | $69 |
| Dexamethasone injection (steroid) | 920 | $0 | $3 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 516 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 435 | $47 | $189 |
| Injection of additional new drug or substance into vein | 297 | $12 | $61 |
| Office visit, established patient (20-29 min) | 191 | $63 | $239 |
| Administration of chemotherapy into vein, 1 hour or less | 174 | $98 | $378 |
| Infusion into a vein for hydration, each additional hour | 168 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 167 | $15 | $56 |
| Injection, diphenhydramine hcl, up to 50 mg | 151 | $1 | $3 |
| Injection, zoledronic acid, 1 mg | 127 | $7 | $69 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 114 | $22 | $84 |
| Infusion, normal saline solution , 1000 cc | 100 | $2 | $7 |
| Office visit, established patient, complex (40-54 min) | 71 | $137 | $474 |
| Red blood count, automated test | 64 | $4 | $10 |
| Injection of drug or substance into vein | 56 | $27 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 50 | $3 | $11 |
| Infusion into a vein for hydration, 31-60 minutes | 49 | $24 | $156 |
| New patient office visit (45-59 min) | 48 | $122 | $453 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 48 | $17 | $59 |
| Administration of chemotherapy into vein, each additional hour | 40 | $21 | $79 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 39 | $401 | $680 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 36 | $1,105 | $3,706 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 21 | $134 | $467 |
| Ct scan of chest with contrast | 20 | $60 | $344 |
| CT scan of abdomen and pelvis with contrast | 14 | $166 | $550 |
| New patient office visit, complex (60-74 min) | 13 | $173 | $585 |
| Initial hospital admission, moderate complexity | 12 | $100 | $377 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.9% high complexity
51.9% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,279
Total received (2018-2024)
Avg $3,468/year across 7 years
Top 19% in FL for hematology
98
Companies
1,237
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,213 (95.6%)
Other
Charitable contributions, space rental, and other categories
$667 (2.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$399 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,238
2023$4,714
2022$4,226
2021$3,021
2020$2,610
2019$2,902
2018$2,567
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,959
Novartis Pharmaceuticals Corporation
$1,760
E.R. Squibb & Sons, L.L.C.
$1,524
PFIZER INC.
$983
Amgen Inc.
$926
Genentech USA, Inc.
$855
Celgene Corporation
$845
GENZYME CORPORATION
$783
Janssen Biotech, Inc.
$761
Incyte Corporation
$749
Lilly USA, LLC
$719
Seagen Inc.
$717
Astellas Pharma US Inc
$699
Eisai Inc.
$666
GlaxoSmithKline, LLC.
$611
Daiichi Sankyo Inc.
$595
Merck Sharp & Dohme LLC
$537
Merck Sharp & Dohme Corporation
$536
Bayer HealthCare Pharmaceuticals Inc.
$523
Exelixis Inc.
$467
Takeda Pharmaceuticals U.S.A., Inc.
$396
Gilead Sciences, Inc.
$391
Regeneron Healthcare Solutions, Inc.
$309
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Kite Pharma, Inc.
$283
EISAI INC.
$233
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
Bayer Healthcare Pharmaceuticals Inc.
$198
Karyopharm Therapeutics Inc.
$195
Pharmacyclics LLC, An AbbVie Company
$185
AbbVie Inc.
$184
Alexion Pharmaceuticals, Inc.
$179
BeiGene USA, Inc.
$171
MENARINI SILICON BIOSYSTEMS, INC.
$168
JAZZ PHARMACEUTICALS INC.
$164
Seattle Genetics, Inc.
$145
EMD Serono, Inc.
$140
Mirati Therapeutics, Inc.
$136
Pharmacosmos Therapeutics Inc.
$128
ARRAY BIOPHARMA INC
$125
Deciphera Pharmaceuticals Inc.
$123
Myovant Sciences Inc.
$111
SOBI, INC
$111
Agios Pharmaceuticals, Inc.
$110
AVEO Pharmaceuticals, Inc.
$109
TESARO, Inc.
$108
Janssen Pharmaceuticals, Inc
$102
Stemline Therapeutics Inc.
$94
G1 Therapeutics, Inc.
$86
TerSera Therapeutics LLC
$83
Sirtex Medical Inc
$81
PUMA BIOTECHNOLOGY, INC.
$79
Rigel Pharmaceuticals, Inc.
$73
TAIHO ONCOLOGY, INC.
$68
Sumitomo Pharma America, Inc.
$63
Blueprint Medicines Corporation
$63
Sobi, Inc
$61
Acceleron Pharma, Inc.
$60
Helsinn Therapeutics (U.S.), Inc.
$59
Puma Biotechnology, Inc.
$56
AbbVie, Inc.
$54
Aveo Pharmaceuticals, Inc.
$53
INSYS Therapeutics Inc
$52
Myriad Genetic Laboratories, Inc.
$48
Clovis Oncology, Inc.
$45
SERVIER PHARMACEUTICALS LLC
$44
Kyowa Kirin, Inc.
$43
MorphoSys, US Inc.
$43
Pharmacyclics LLC, an AbbVie Company
$42
Shire North American Group Inc
$42
AMAG Pharmaceuticals, Inc.
$42
Horizon Therapeutics plc
$42
Taiho Oncology, Inc.
$39
PharmaEssentia USA Corporation
$36
Dova Pharmaceuticals
$34
Catalyst Pharmaceuticals, Inc.
$33
ABBVIE INC.
$33
Aurobindo Pharma USA, Inc.
$31
ImmunoGen, Inc.
$30
Global Blood Therapeutics, Inc.
$26
Servier Pharmaceuticals LLC
$23
Fennec Pharmaceuticals, Inc.
$20
Heron Therapeutics, Inc.
$20
GE HealthCare
$20
Legend Biotech USA Inc.
$20
MEDIVATION FIELD SOLUTIONS LLC
$19
CTI BioPharma Corp.
$19
ADC Therapeutics America, Inc.
$18
Epizyme, Inc.,
$17
Array BioPharma Inc.
$16
Dendreon Pharmaceuticals LLC
$15
CSL Behring
$15
Novocure Inc.
$15
Sun Pharmaceutical Industries Inc.
$14
SANOFI-AVENTIS U.S. LLC
$13
Spectrum Pharmaceuticals Inc.
$12
NanoString Technologies, Inc.
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CERDELGA · CHANTIX · CINVANTI · COSELA · CREON · CUVITRU · CYRAMZA · Cabometyx · Cellsearch · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Elahere · Enhertu · Erleada · FASLODEX · FERAHEME · FIRDAPSE · FOTIVDA · FRUZAQLA · Fabhalta · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GLYXAMBI · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · INVOKANA · Idelvion · Imbruvica · Inrebic · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Marqibo · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Pomalyst · QINLOCK · RAYOS · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Repatha · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · SYNDROS · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · Voranigo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xolair · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $24 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
46
Per 100K population
3.1
County median income
$75,011
Nearest hospital
ST JOSEPHS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Chatoor is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 19%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Chatoor experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Chatoor performed 33,660 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chatoor receive payments from pharmaceutical companies?
Yes. Dr. Chatoor received a total of $24,279 from 98 companies across 1,237 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chatoor's costs compare to other hematologys in Tampa?
Dr. Chatoor's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chatoor) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in Tampa
Browse hematologys in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology